Pelvic lining removal study for early ovarian cancer
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial studies removing the pelvic lining (peritoneum) during surgery for early-stage ovarian or fallopian tube tumors. It aims to see if this extra step improves outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have early-stage (IA or IB) ovarian or fallopian tube cancer, confirmed by standard tests.
- You have had a complete workup including ultrasound, CT scan, and tumor markers.
- You are planning to have surgery (laparoscopic, robotic, or open) to remove your tumor.
- You are willing and able to provide written consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks back at different surgical methods (open or minimally invasive) used for early-stage epithelial ovarian cancer. It aims to compare outcomes and help doctors choose the best approach.
This trial checks whether having surgery to remove as much tumor as possible, followed by ongoing targeted treatment, helps people with advanced ovarian (and related) cancers live longer and/or control cancer better. It specifically uses tumor-testing results to match patients and then continues treatment after surgery.
This trial studies whether doing surgery using smaller incisions after chemotherapy works as well as a more traditional approach for certain people with stage IIIC–IV ovarian, fallopian tube, or primary peritoneal cancer. It may help reduce surgical trauma while aiming for effective tumor removal.
This trial studies whether removing (dissecting) lymph nodes during surgery can improve care for people with early-stage ovarian cancer that still needs chemotherapy. You may be eligible if you have certain ovarian cancer types and your scans and surgery do not show clearly suspicious lymph nodes.
This trial looks at whether removing as much tumor as possible with surgery can help people whose ovarian/peritoneal/fallopian tube cancer comes back quickly after platinum chemotherapy. It targets cases where the recurrence is limited and may be safely removed, then compares outcomes to standard care.
This trial tests whether using a small-scope (minimally invasive) surgery instead of a large incision can safely remove remaining ovarian cancer after chemotherapy. It may mean a faster recovery and fewer complications.
Hear when a new Peritoneal Carcinosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.